SARS‐CoV‐2, the Virus that Causes COVID‐19: Cytometry and the New Challenge for Global Health-Reference-Cited by-同舟云学术

SARS‐CoV‐2, the Virus that Causes COVID‐19: Cytometry and the New Challenge for Global Health

Published:2020-03-18 Issue:4 Volume:97 Page:340-343
ISSN:1552-4922
Container-title:Cytometry Part A
language:en
Short-container-title:Cytometry

Author:

Cossarizza Andrea¹,De Biasi Sara¹,Guaraldi Giovanni²,Girardis Massimo³,Mussini Cristina²,

Affiliation:

1. Department of Medical and Surgical Sciences for Children and Adults University of Modena and Reggio Emilia School of Medicine, Via Campi 287 41125 Modena Italy

2. Infectious Diseases Clinics University Hospital, via del Pozzo 71 41124 Modena Italy

3. Department of Anesthesia and Intensive Care University Hospital, via del Pozzo 71 41124 Modena Italy

Publisher

Wiley

Subject

Cell Biology,Histology,Pathology and Forensic Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cyto.a.24002

Reference18 articles.

1. WHO Novel coronavirus ‐ China Jan 12 2020.https://www.who.int/csr/don/12-january-2020-novel-coronavirus-china/en/

2. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

4. Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

5. First Case of 2019 Novel Coronavirus in the United States

Cited by 102 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of COVID-19 in patients with obinutuzumab compared with patients with rituximab: a retrospective cohort study;Virology Journal;2024-09-09

2. A Correlation Study to Comprehend the SAR-CoV-2 Viral Load, Antiviral Antibody Titer, and Severity of COVID-19 Symptoms Post-infection Amongst the Vaccinated Population in Kamrup District of As sam, Northeast India;Endocrine, Metabolic & Immune Disorders - Drug Targets;2024-09

3. Immunosenescence and vaccine efficacy revealed by immunometabolic analysis of SARS-CoV-2-specific cells in multiple sclerosis patients;Nature Communications;2024-03-29

4. Changes in the innate immune response to SARS-CoV-2 with advancing age in humans;Immunity & Ageing;2024-03-21

5. Analysis of (COVID)-19 Epidemic Transmission Risks and Policy Handling in Chinese Campuses;American Journal of Health Behavior;2023-12-31